TKG Advisors LLC Acquires 409 Shares of Danaher Corporation $DHR

TKG Advisors LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 4.7% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,085 shares of the conglomerate’s stock after acquiring an additional 409 shares during the quarter. TKG Advisors LLC’s holdings in Danaher were worth $1,795,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Simmons Bank increased its position in shares of Danaher by 4.3% in the second quarter. Simmons Bank now owns 26,831 shares of the conglomerate’s stock worth $5,300,000 after purchasing an additional 1,095 shares during the last quarter. Ellevest Inc. increased its holdings in shares of Danaher by 5.0% in the 2nd quarter. Ellevest Inc. now owns 2,892 shares of the conglomerate’s stock worth $571,000 after buying an additional 137 shares during the last quarter. Crestwood Advisors Group LLC increased its holdings in shares of Danaher by 2.6% in the 2nd quarter. Crestwood Advisors Group LLC now owns 329,621 shares of the conglomerate’s stock worth $65,114,000 after buying an additional 8,441 shares during the last quarter. Jacobson & Schmitt Advisors LLC increased its holdings in shares of Danaher by 2.9% in the 2nd quarter. Jacobson & Schmitt Advisors LLC now owns 94,734 shares of the conglomerate’s stock worth $18,714,000 after buying an additional 2,628 shares during the last quarter. Finally, NewSquare Capital LLC increased its holdings in shares of Danaher by 100.5% in the 2nd quarter. NewSquare Capital LLC now owns 425 shares of the conglomerate’s stock worth $84,000 after buying an additional 213 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

Shares of Danaher stock opened at $213.89 on Wednesday. The firm has a market cap of $151.08 billion, a PE ratio of 44.10, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The company’s fifty day simple moving average is $203.68 and its two-hundred day simple moving average is $199.98. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s payout ratio is presently 26.39%.

Analyst Ratings Changes

A number of research analysts recently commented on DHR shares. Royal Bank Of Canada set a $241.00 target price on Danaher in a research note on Tuesday, September 2nd. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a research report on Friday, July 11th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. TD Cowen increased their price objective on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.